OSI Pharmaceuticals Inc.

OSIP-Q

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about OSIP-Q

Signal
Opinion
Expert
TOP PICK
TOP PICK
August 13, 2004
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
Samuel D. Isaly
Portfolio Manager, Eaton Vance Worldwide
Price
$53.710
Owned
Yes
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »